Relief Therapeutics (OTCMKTS:RLFTF) Stock Price Down 4.7% – Here’s What Happened

Relief Therapeutics Holding SA (OTCMKTS:RLFTF)’s share price was down 4.7% during trading on Friday . The company traded as low as $0.41 and last traded at $0.41. Approximately 1,142 shares changed hands during trading, a decline of 60% from the average daily volume of 2,875 shares. The stock had previously closed at $0.43.

Relief Therapeutics Price Performance

The firm has a 50-day moving average price of $0.58 and a two-hundred day moving average price of $1.98.

Relief Therapeutics Company Profile

Relief Therapeutics AG is a clinical‐stage biopharmaceutical company focused on the development of novel therapies for rare and critical care indications. Headquartered in Geneva, Switzerland, the company leverages its expertise in peptide biology to address diseases with high unmet need, including acute respiratory distress syndrome (ARDS) and other serious pulmonary and inflammatory conditions.

The company’s lead product candidate, RLF‐100 (aviptadil), is a synthetic formulation of vasoactive intestinal peptide (VIP) being evaluated for the treatment of ARDS and COVID-19–associated respiratory failure.